Dopamine D3 receptor gene polymorphism and the psychiatric symptoms seen in first-break schizophrenic patients

T. Inada, T. Sugita, I. Dobashi, A. Inagaki, Y. Kitao, G. Matsuda, Shingo Kato, T. Takano, G. Yagi, M. Asai

Research output: Contribution to journalArticle

23 Citations (Scopus)

Abstract

To investigate the possible effect of polymorphism at the BalI site of the dopamine D3 receptor gene (DRD3) on the phenotype in human subjects, allele and genotype frequencies for this polymorphic site were examined in 113 schizophrenic patients, including six subgroups, and 48 normal controls. The schizophrenic subgroups included patients with early onset, those with a family history, and those who suffered from one of the following psychiatric symptoms at their first episode: (1) delusion and hallucination; (2) disorganization; (3) bizarre behavior; and (4) negative symptoms. No significant differences were observed in genotype, allele and homozygosity frequencies between the whole group or any subgroup of schizophrenic patients and the controls. The present results indicate that polymorphism at the Ball site of the (DRD3 is unlikely to be a major contributor to any of the psychiatric parameters examined in the present population of schizophrenic subjects.

Original languageEnglish
Pages (from-to)113-116
Number of pages4
JournalPsychiatric Genetics
Volume5
Issue number3
Publication statusPublished - 1995

Fingerprint

Dopamine D3 Receptors
Psychiatry
Gene Frequency
Genotype
Genes
Delusions
Hallucinations
Phenotype
Population

Keywords

  • Bali polymorphism
  • Bizarre behaviour
  • Delusion
  • Disorganization
  • Dopamine D3 receptor gene
  • Hallucination
  • Negative symptoms
  • Schizophrenia

ASJC Scopus subject areas

  • Genetics(clinical)
  • Psychiatry and Mental health
  • Genetics
  • Neuroscience(all)

Cite this

Inada, T., Sugita, T., Dobashi, I., Inagaki, A., Kitao, Y., Matsuda, G., ... Asai, M. (1995). Dopamine D3 receptor gene polymorphism and the psychiatric symptoms seen in first-break schizophrenic patients. Psychiatric Genetics, 5(3), 113-116.

Dopamine D3 receptor gene polymorphism and the psychiatric symptoms seen in first-break schizophrenic patients. / Inada, T.; Sugita, T.; Dobashi, I.; Inagaki, A.; Kitao, Y.; Matsuda, G.; Kato, Shingo; Takano, T.; Yagi, G.; Asai, M.

In: Psychiatric Genetics, Vol. 5, No. 3, 1995, p. 113-116.

Research output: Contribution to journalArticle

Inada, T, Sugita, T, Dobashi, I, Inagaki, A, Kitao, Y, Matsuda, G, Kato, S, Takano, T, Yagi, G & Asai, M 1995, 'Dopamine D3 receptor gene polymorphism and the psychiatric symptoms seen in first-break schizophrenic patients', Psychiatric Genetics, vol. 5, no. 3, pp. 113-116.
Inada T, Sugita T, Dobashi I, Inagaki A, Kitao Y, Matsuda G et al. Dopamine D3 receptor gene polymorphism and the psychiatric symptoms seen in first-break schizophrenic patients. Psychiatric Genetics. 1995;5(3):113-116.
Inada, T. ; Sugita, T. ; Dobashi, I. ; Inagaki, A. ; Kitao, Y. ; Matsuda, G. ; Kato, Shingo ; Takano, T. ; Yagi, G. ; Asai, M. / Dopamine D3 receptor gene polymorphism and the psychiatric symptoms seen in first-break schizophrenic patients. In: Psychiatric Genetics. 1995 ; Vol. 5, No. 3. pp. 113-116.
@article{4cc7736b8e404d089e2b049d70d3b196,
title = "Dopamine D3 receptor gene polymorphism and the psychiatric symptoms seen in first-break schizophrenic patients",
abstract = "To investigate the possible effect of polymorphism at the BalI site of the dopamine D3 receptor gene (DRD3) on the phenotype in human subjects, allele and genotype frequencies for this polymorphic site were examined in 113 schizophrenic patients, including six subgroups, and 48 normal controls. The schizophrenic subgroups included patients with early onset, those with a family history, and those who suffered from one of the following psychiatric symptoms at their first episode: (1) delusion and hallucination; (2) disorganization; (3) bizarre behavior; and (4) negative symptoms. No significant differences were observed in genotype, allele and homozygosity frequencies between the whole group or any subgroup of schizophrenic patients and the controls. The present results indicate that polymorphism at the Ball site of the (DRD3 is unlikely to be a major contributor to any of the psychiatric parameters examined in the present population of schizophrenic subjects.",
keywords = "Bali polymorphism, Bizarre behaviour, Delusion, Disorganization, Dopamine D3 receptor gene, Hallucination, Negative symptoms, Schizophrenia",
author = "T. Inada and T. Sugita and I. Dobashi and A. Inagaki and Y. Kitao and G. Matsuda and Shingo Kato and T. Takano and G. Yagi and M. Asai",
year = "1995",
language = "English",
volume = "5",
pages = "113--116",
journal = "Psychiatric Genetics",
issn = "0955-8829",
publisher = "Lippincott Williams and Wilkins",
number = "3",

}

TY - JOUR

T1 - Dopamine D3 receptor gene polymorphism and the psychiatric symptoms seen in first-break schizophrenic patients

AU - Inada, T.

AU - Sugita, T.

AU - Dobashi, I.

AU - Inagaki, A.

AU - Kitao, Y.

AU - Matsuda, G.

AU - Kato, Shingo

AU - Takano, T.

AU - Yagi, G.

AU - Asai, M.

PY - 1995

Y1 - 1995

N2 - To investigate the possible effect of polymorphism at the BalI site of the dopamine D3 receptor gene (DRD3) on the phenotype in human subjects, allele and genotype frequencies for this polymorphic site were examined in 113 schizophrenic patients, including six subgroups, and 48 normal controls. The schizophrenic subgroups included patients with early onset, those with a family history, and those who suffered from one of the following psychiatric symptoms at their first episode: (1) delusion and hallucination; (2) disorganization; (3) bizarre behavior; and (4) negative symptoms. No significant differences were observed in genotype, allele and homozygosity frequencies between the whole group or any subgroup of schizophrenic patients and the controls. The present results indicate that polymorphism at the Ball site of the (DRD3 is unlikely to be a major contributor to any of the psychiatric parameters examined in the present population of schizophrenic subjects.

AB - To investigate the possible effect of polymorphism at the BalI site of the dopamine D3 receptor gene (DRD3) on the phenotype in human subjects, allele and genotype frequencies for this polymorphic site were examined in 113 schizophrenic patients, including six subgroups, and 48 normal controls. The schizophrenic subgroups included patients with early onset, those with a family history, and those who suffered from one of the following psychiatric symptoms at their first episode: (1) delusion and hallucination; (2) disorganization; (3) bizarre behavior; and (4) negative symptoms. No significant differences were observed in genotype, allele and homozygosity frequencies between the whole group or any subgroup of schizophrenic patients and the controls. The present results indicate that polymorphism at the Ball site of the (DRD3 is unlikely to be a major contributor to any of the psychiatric parameters examined in the present population of schizophrenic subjects.

KW - Bali polymorphism

KW - Bizarre behaviour

KW - Delusion

KW - Disorganization

KW - Dopamine D3 receptor gene

KW - Hallucination

KW - Negative symptoms

KW - Schizophrenia

UR - http://www.scopus.com/inward/record.url?scp=0029588442&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0029588442&partnerID=8YFLogxK

M3 - Article

VL - 5

SP - 113

EP - 116

JO - Psychiatric Genetics

JF - Psychiatric Genetics

SN - 0955-8829

IS - 3

ER -